The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery

Angela Collarino1,2, Renato A. Valdés Olmos1,3, Lotta G.A.J. van Berkel4, Peter A. Neijenhuis5, L Wijers4, Frits Smit6,1, Lioe-Fee de Geus-Oei2,1, Lenka M. Pereira Arias-Bouda6,1
1Section of Nuclear Medicine, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
2Biomedical Photonic Imaging Group, MIRA Institute, University of Twente, Enschede, The Netherlands
3Department of Nuclear Medicine, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
4Department of Radiology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands
5Department of Surgery, Alrijne Ziekenhuis, Leiderdorp, The Netherlands
6Department of Nuclear Medicine, Alrijne Ziekenhuis, Leiderdorp, The Netherlands

Tóm tắt

Từ khóa


Tài liệu tham khảo

Netherlands Cancer Registry. http://www.cijfersoverkanker.nl . Accessed 02 Nov 2016

International Agency for Research on Cancer (IARC) and World Health Organization (WHO). GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx . Accessed 03 Jan 2018

Clough KB, Kaufman GJ, Nos C, Buccimazza I, Sarfati IM (2010) Improving breast cancer surgery: a classification and quadrant per quadrant atlas for oncoplastic surgery. Ann Surg Oncol 17(5):1375–1391

Winchester DP, Cox JD (1992) Standards for breast-conservation treatment. CA Cancer J Clin 42(3):134–162

Gradishar WJ, Anderson BO, Balassanian R et al (2016) Breast cancer version 2.2016, NCCN Clinical Practice Guidelines in Oncology. http://www.nccn.org/professionals/physician_gls/pdf/breat.pdf . Accessed 02 Nov 2016

Goldsmith SJ, Parsons W, Guiberteau MJ, Stern LH, Lanzkowsky L, Weigert J, Heston TF, Jones E, Buscombe J, Stabin MG, Society of Nuclear Medicine (2010) SNM practice guideline for breast scintigraphy with breast-specific gamma-cameras 1.0. J Nucl Med Technol 38(4):219–224

Brem RF, Schoonjans JM, Kieper DA, Majewski S, Goodman S, Civelek C (2002) High-resolution scintimammography: a pilot study. J Nucl Med 43(7):909–915

Rhodes DJ, O’Connor MK, Phillips SW, Smith RL, Collins DA (2005) Molecular breast imaging: a new technique using technetium Tc 99 m scintimammography to detect small tumors of the breast. Mayo Clin Proc 80(1):24–30

Jones EA, Phan TD, Blanchard DA, Miley A (2009) Breast-specific gamma-imaging: molecular imaging of the breast using 99 mTc-sestamibi and a small-field-of-view gamma-camera. J Nucl Med Technol 37(4):201–205

Weinmann AL, Hruska CB, O’Connor MK (2009) Design of optimal collimation for dedicated molecular breast imaging systems. Med Phys 36(3):845–856

Hruska CB, Weinmann AL, Tello Skjerseth CM, Wagenaar EM, Conners AL, Tortorelli CL, Maxwell RW, Rhodes DJ, O’Connor MK (2012) Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. Part II. Evaluation in patients. Med Phys 39(6):3476–3483

Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Schubert EK, Charlop AW, Tseng J, Rinn KJ, Livingston RB (2002) [Tc-99 m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow. Nucl Med Biol 29(7):719–727

Scopinaro F, Schillaci O, Scarpini M, Mingazzini PL, Di Macio L, Banci M, Danieli R, Zerilli M, Limiti MR, Centi Colella A (1994) Technetium-99 m sestamibi: an indicator of breast cancer invasiveness. Eur J Nucl Med 21(9):984–987

Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG (1990) Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99 m by human carcinoma cell lines in vitro. Cancer Res 50(7):2198–2202

Brem RF, Ruda RC, Yang JL, Coffey CM, Rapelyea JA (2016) Breast-specific γ-imaging for the detection of mammographically occult breast cancer in women at increased risk. J Nucl Med 57(5):678–684

Kuhn KJ, Rapelyea JA, Torrente J, Teal CB, Brem RF (2016) Comparative diagnostic utility of low-dose breast-specific gamma imaging to current clinical standard. Breast J 22(2):180–188

Long Z, Conners AL, Hunt KN, Hruska CB, O’Connor MK (2016) Performance characteristics of dedicated molecular breast imaging systems at low doses. Med Phys 43(6):3062–3070

O’Connor MK (2015) Molecular breast imaging: an emerging modality for breast cancer screening. Breast Cancer Manag 4(1):33–40

Conners AL, Hruska CB, Tortorelli CL, Maxwell RW, Rhodes DJ, Boughey JC, Berg WA (2012) Lexicon for standardized interpretation of gamma camera molecular breast imaging: observer agreement and diagnostic accuracy. Eur J Nucl Med Mol Imaging 39(6):971–982

Spanu A, Sanna D, Chessa F, Manca A, Cottu P, Fancellu A, Nuvoli S, Madeddu G (2012) The clinical impact of breast scintigraphy acquired with a breast specific γ-camera (BSGC) in the diagnosis of breast cancer: incremental value versus mammography. Int J Oncol 41(2):483–489

Kieper DA, Welch BL, Fairchild LH, inventors; Dilon Technologies, Inc., assignee (2012) Gamma guided stereotactic localization system. US Patent US8249693. 21 Aug 2012

Collarino A, Valdés Olmos RA, van der Hoeven AF, Pereira Arias-Bouda LM (2016) Methodological aspects of 99mTc-sestamibi guided biopsy in breast cancer. Clin Transl Imaging 4(5):367–376

Collarino A, Olmos RAV, Neijenhuis PA, den Hartog WC, Smit F, de Geus-Oei LF, Arias-Bouda LMP (2017) First Clinical Experience Using Stereotactic Breast Biopsy Guided by (99m)Tc-Sestamibi. AJR Am J Roentgenol 209(6):1367–1373

Lee A, Chang J, Lim W, Kim BS, Lee JE, Cha ES, Moon BI (2012) Effectiveness of breast-specific gamma imaging (BSGI) for breast cancer in Korea: a comparative study. Breast J 18(5):453–458

Killelea BK, Gillego A, Kirstein LJ, Asad J, Shpilko M, Shah A, Feldman S, Boolbol SK (2009) George Peters Award: how does breast-specific gamma imaging affect the management of patients with newly diagnosed breast cancer? Am J Surg 198(4):470–474

Zhou M, Johnson N, Gruner S, Ecklund GW, Meunier P, Bryn S, Glissmeyer M, Steinbock K (2009) Clinical utility of breast-specific gamma imaging for evaluating disease extent in the newly diagnosed breast cancer patient. Am J Surg 197(2):159–163

Brem RF, Floerke AC, Rapelyea JA, Teal C, Kelly T, Mathur V (2008) Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. Radiology 247(3):651–657

Brem RF, Shahan C, Rapleyea JA, Donnelly CA, Rechtman LR, Kidwell AB, Teal CB, McSwain A, Torrente J (2010) Detection of occult foci of breast cancer using breast-specific gamma imaging in women with one mammographic or clinically suspicious breast lesion. Acad Radiol 17(6):735–743

Zhou M, Johnson N, Blanchard D, Bryn S, Nelson J (2008) Real-world application of breast-specific gamma imaging, initial experience at a community breast center and its potential impact on clinical care. Am J Surg 195(5):631–635

Sun Y, Wei W, Yang HW, Liu JL (2013) Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis. Eur J Nucl Med Mol Imaging 40(3):450–463

Berg WA, Blume JD, Adams AM, Jong RA, Barr RG, Lehrer DE, Pisano ED, Evans WP 3rd, Mahoney MC, Hovanessian Larsen L, Gabrielli GJ, Mendelson EB (2010) Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: aCRIN 6666. Radiology 254(1):79–87

Van den Wyngaert T, Strobel K, Kampen WU et al (2016) The EANM practice guidelines for bone scintigraphy. Eur J Nucl Med Mol Imaging 43(9):1723–1738

Verberne HJ, Acampa W, Anagnostopoulos C et al (2015) EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging 42(12):1929–1940